We confirmed the anticancer potential of Mito-T (4) as a solitary agent in the NCI60 panel (Figure S4) and found that leukemia and breast cancer mobile line groups were far more delicate in the SRB assay than other cell traces
To even more dissect the specific proteins that are oxidized and the likely mechanistic...